Kaytan E - Search Results

1

High-dose epirubicin and cisplatin in locally advanced undifferentiated nasopharyngeal carcinoma.

Onat H, Basaran M, Esassolak M, Bavbek SE, Anacak Y, Kaytan E, Altun M, Haydaroglu A. Onat H, et al. Among authors: kaytan e. Clin Oncol (R Coll Radiol). 2002 Dec;14(6):449-54. doi: 10.1053/clon.2002.0110. Clin Oncol (R Coll Radiol). 2002. PMID: 12512965 Clinical Trial.

2

Aggressive non-Hodgkin's lymphoma treated at the Institute of Oncology, Istanbul: treatment, outcome, and prognostic factors.

Alici S, Bavbek SE, Kaytan E, Başaran M, Eralp Y, Onat H. Alici S, et al. Among authors: kaytan e. Am J Clin Oncol. 2002 Oct;25(5):502-8. doi: 10.1097/00000421-200210000-00016. Am J Clin Oncol. 2002. PMID: 12393993

3

Prognostic factors in localized aggressive non-Hodgkin's lymphoma.

Alici S, Bavbek SE, Kaytan E, Eralp Y, Onat H. Alici S, et al. Among authors: kaytan e. Am J Clin Oncol. 2003 Feb;26(1):1-5. doi: 10.1097/00000421-200302000-00001. Am J Clin Oncol. 2003. PMID: 12576915

4

Prognostic factors and survival in late adolescent and adult patients with small round cell tumors.

Eralp Y, Bavbek S, Başaran M, Kaytan E, Yaman F, Bilgiç B, Darendeliler E, Onat H. Eralp Y, et al. Among authors: kaytan e. Am J Clin Oncol. 2002 Aug;25(4):418-24. doi: 10.1097/00000421-200208000-00020. Am J Clin Oncol. 2002. PMID: 12151977

5

Prognostic significance of hemoglobin concentration in nasopharyngeal carcinoma: does treatment-induced anemia have negative effect?

Altun M, Demiral AN, Meral R, Kaytan E, Cosar R, Disci R, Dizdar Y. Altun M, et al. Among authors: kaytan e. In Vivo. 2003 Sep-Oct;17(5):483-7. In Vivo. 2003. PMID: 14598613

6

Timing of death from tumor recurrence after curative gastrectomy for gastric cancer.

Sakar B, Karagol H, Gumus M, Basaran M, Kaytan E, Argon A, Ustuner Z, Bavbek SE, Bugra D, Aykan FN. Sakar B, et al. Among authors: kaytan e. Am J Clin Oncol. 2004 Apr;27(2):205-9. doi: 10.1097/01.coc.0000092703.12189.a2. Am J Clin Oncol. 2004. PMID: 15057162

7

Preliminary analysis of a phase II study of Paclitaxel and CHART in locally advanced non-small cell lung cancer.

Oral EN, Bavbek S, Kizir A, Tenececi N, Yöney A, Kaytan E, Topuz E. Oral EN, et al. Among authors: kaytan e. Lung Cancer. 1999 Sep;25(3):191-8. doi: 10.1016/s0169-5002(99)00068-9. Lung Cancer. 1999. PMID: 10512130 Clinical Trial.

8

Survival outcomes in aggressive non-Hodgkin's lymphoma according to the International Prognostic Index.

Alici S, Bavbek SE, Kaytan E, Basaran M, Bulutlar G, Onat H. Alici S, et al. Among authors: kaytan e. J BUON. 2003 Apr-Jun;8(2):121-6. J BUON. 2003. PMID: 17472237

9

Locally advanced nasopharyngeal carcinoma: computed tomography findings, clinical evaluation, and treatment outcome.

Altun M, Tenekeci N, Kaytan E, Meral R. Altun M, et al. Among authors: kaytan e. Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):401-4. doi: 10.1016/s0360-3016(00)00426-0. Int J Radiat Oncol Biol Phys. 2000. PMID: 10802366

10

Childhood nasopharyngeal carcinoma: from biology to treatment.

Ayan I, Kaytan E, Ayan N. Ayan I, et al. Among authors: kaytan e. Lancet Oncol. 2003 Jan;4(1):13-21. doi: 10.1016/s1470-2045(03)00956-2. Lancet Oncol. 2003. PMID: 12517535 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters